Axsome Therapeutics said on April 25 the company expects the U.S. health regulator to decline approval for the drug developer’s treatment of acute migraine over unresolved issues of its quality control processes, sending shares of Axsome down 20 percent.
Prices increased on 810 different medications by the end of January 2021, not only on branded medications but also some generic drugs, according to a pricing report from GoodRx Health.
Nearly 30 generic drugmakers in Asia, Africa and the Middle East will make cheap versions of Merck & Co’s COVID-19 pill, under a landmark U.N.-backed deal to give poorer nations wider access to a drug seen as a weapon in fighting the pandemic.
A World Health Organization committee urged COVID-19 vaccine manufacturers on January 18 to provide the data it requires in order to list their shots for emergency use, saying the delays were affecting equitable vaccine access.
Months after landing a massive SPAC deal that carried Ginkgo Bioworks to the Nasdaq, the company is touting a manufacturing breakthrough from partner Aldevron for mRNA vaccine components.
BioSpace takes a look at the flurry of expansion activity in the life sciences industry as biopharma and diagnostic companies expand manufacturing sites.
With an $850 million investment from parent company Fujifilm Corporation, Fujifilm Diosynth Biotechnologies is expanding the company’s manufacturing capabilities to support an increased capacity for biologics and gene therapies.
Moderna Inc. said on April 29 the company is boosting manufacturing capacity for its Covid-19 vaccine and expects to make up to 3 billion doses in 2022, more than twice the previous forecast.
Emergent BioSolutions Inc. said on April 4 that a key U.S. agency increased an order, related to the manufacturing of Johnson & Johnson’s Covid-19 vaccine, by $23 million.
Manufacturing capacity and ingredients shortages are the main bottlenecks to expanding Covid-19 vaccine production, several global drug groups said on March 9, not patents that some critics are demanding be removed.